ライフサイエンスコーパス: formulary

1 because it is not available on the hospital formulary).

2 administers its own benefit using a national formulary.

3 resource-poor world who work with a limited formulary.

4 in control over cancer drugs is the hospital formulary.

5 ric cyclosporine formulation on our hospital formulary.

6 increased in provinces with the most lenient formularies.

7 bia and Alberta, which have more restrictive formularies.

8 hat all of these medications are included in formularies.

9 rage for one such agent include all on their formularies (a revised version would preclude a trial of

10 Different changes in formulary administration may have dramatically different

11 red health plans that implemented changes in formulary administration with those in comparison groups

12 Limited formularies and adherence constraints in children jeopar

13 guide countries in the creation of national formularies and policies for access, quality, and use of

14 opayment required for all drugs) to a 3-tier formulary and implemented an across-the-board copayment

15 sly switched from a one-tier to a three-tier formulary and increased all enrollee copayments for medi

16 were obtained from the Ontario Drug Benefits Formulary and the Ontario Case Costing Initiative.

17 nd administrators who want to make coverage, formulary, and purchasing decisions; and policymakers wh

18 priateness of therapy guidelines, antibiotic formulary, antibiotic stewardship programmes, public hea

19 lar benefits and adverse effects, a "stepped formulary" approach requiring an initial trial of one of

20 ing widely covered to include 95% or more of formularies at co-payments of $15 or less still resulted

21 covered (defined as inclusion in >or=90% of formularies at co-payments of <or=$35 without prior auth

22 ase of administration, famotidine because of formulary availability, sucralfate for a better side eff

23 maintain intravenous quinidine gluconate on formulary because it is the only drug available to treat

24 cribe dermatologic medications; as insurance formularies become increasingly restrictive and more pat

25 ond switched from a two-tier to a three-tier formulary, changing only the copayments for tier-3 drugs

26 lows: (1) selection of insurance plans whose formularies cover their medications in a low tier (eg, "

27 th MI to full prescription coverage or usual formulary coverage for all statins, beta-blockers, angio

28 o examine 72 California and 43 Hawaii Part D formularies' coverage of 8 treatment classes (angiotensi

29 Little variation existed in formulary design across plans and products.

30 packages with different prices and different formularies for beneficiaries to choose from.

31 ability in restrictiveness of the provincial formularies, illustrating the potential of a policy resp

32 e copayment increases associated with 3-tier formulary implementation by 1 employer resulted in lower

33 A 3-tier formulary implementation resulted in a 17% decrease in t

34 iption drug formularies, which represent all formularies in 2014.

35 ployers and health plans have adopted 3-tier formularies in an attempt to control costs for these and

36 nd health plans have adopted incentive-based formularies in an attempt to control prescription-drug c

37 To determine whether Part D formularies in California (the state with the most Medic

38 ortantly, to avoid drug toxicities, a larger formulary is needed in resource-poor settings, and this

39 n features studied, including preferred drug/formulary lists, prior authorization, medication dosing/

40 estrictiveness of ezetimibe in public-funded formularies (most to least strict: British Columbia, Alb

41 insulin may not even be included on national formularies of essential drugs.

42 gard to whether drugs are listed on the drug formulary of a country or province.

43 A sufficiently wide formulary of drugs should be developed for those with co

44 was posted in operating rooms and the online formulary, only recommended antibiotics were available i

45 he Medicare July 2014 Prescription Drug Plan Formulary, Pharmacy Network, and Pricing Information Fil

46 The effect of formulary policy on the use of ezetimibe over time is un

47 ese results, IV minocycline was added to the formulary, primarily for the treatment of carbapenem-res

48 prescribing using such "top-down" methods as formulary restriction and prospective audit with feedbac

49 Hospital formulary restriction of clindamycin is an effective way

50 y and compatibility, and the local insurance formulary restriction to deliver an effective glaucoma m

51 g based on local susceptibility patterns and formulary restriction, and avoiding drugs with more prop

52 timicrobials, therapeutic substitutions, and formulary restriction.

53 onsideration, medical insurance coverage, or formulary restriction.

54 Because the current formulary restrictions appear to be unlikely to change q

55 SUP based on prescribing patterns, hospital formulary restrictions, and cost-analysis should be cons

56 r understand the association between use and formulary restrictiveness.

57 Professional (USP-DI), and American Hospital Formulary Service Drug Information (AHFS-DI), to identif

58 Formularies varied substantially; however, all but 1 tre

59 covered for their Medicare patients because formularies vary widely among Medicare Part D plans and

60 Specific information about an individual's formulary was not available, so the authors could not es

61 dicare relies on private plans with distinct formularies, whereas the VA administers its own benefit

62 d 2,230 Medicare Advantage prescription drug formularies, which represent all formularies in 2014.

63 er 35% from a public healthcare insurer drug formulary while maintaining or improving patient care.